Company Filing History:
Years Active: 2014-2018
Title: Shun-Cheng Wu: Innovator in Bone Regeneration
Introduction
Shun-Cheng Wu is a prominent inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of bone regeneration through his innovative methods and research. With a total of 2 patents, his work focuses on improving treatments for bone-related conditions.
Latest Patents
Wu's latest patents include a method for bone formation by administering poly(lactic-co-glycolic acid) cross-linked alendronate. This method involves administering a short-term release composition into a bone area of a subject in need, allowing for effective bone regeneration. The composition releases alendronate into the bone area, ensuring that the bone tissue is exposed to a therapeutically effective amount of the drug over a period of nine days. Another notable patent is for a method of controlled release of parathyroid hormone from cross-linked hyaluronic acid hydrogel. This method provides a locally controlled release of PTH(1-34) through a hyaluronic acid-based hydrogel, which can be injected intra-articularly for the treatment of osteoarthritis.
Career Highlights
Shun-Cheng Wu is affiliated with Kaohsiung Medical University, where he conducts his research and develops his innovative methods. His work has garnered attention in the medical community for its potential to enhance bone healing and regeneration.
Collaborations
Wu collaborates with esteemed colleagues such as Mei-Ling Ho and Je-Ken Chang, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Shun-Cheng Wu's contributions to the field of bone regeneration through his patents and research at Kaohsiung Medical University highlight his role as a leading inventor. His innovative methods have the potential to significantly impact the treatment of bone-related conditions.